InsightfulValue
← Home

Ono Pharmaceutical
Ono Pharmaceutical

Pharma / Pharmaceuticals, Healthcare


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Ono Pharmaceutical

πŸ“Š Get full analytics about Ono Pharmaceutical

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

Price
Live  
Overview
Ono Pharmaceutical Co., Ltd. is a Japanese-based pharmaceutical company that was founded in 1717. The company develops, manufactures, and sells prescription medicines and over-the-counter products for a wide range of medical conditions. Ono Pharmaceutical is headquartered in Osaka, Japan and has operations in Asia, Europe, and the United States.
The company focuses on research and development in the fields of oncology, immunology, and neurology. Its products include treatments for cancer, immune disorders, infectious diseases, and other areas of unmet medical need.
Ono Pharmaceutical is committed to ethical business practices and responsible corporate citizenship. The company has implemented various initiatives to reduce its environmental impact and contribute to the well-being of communities it operates in.
Ono Pharmaceutical has collaborations and partnerships with other pharmaceutical companies, research institutions, and universities to enhance its research capabilities and bring innovative medicines to patients.
Overall, Ono Pharmaceutical is dedicated to improving the health and quality of life of individuals worldwide through the development of innovative and effective medications.
What is special about the company?
Ono Pharmaceutical

πŸ“ˆ Want to read more about Ono Pharmaceutical?

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

MS4gRm9jdX NlZCBvbiBS ZXNlYXJjaC BhbmQgRGV2 ZWxvcG1lbn Q6IE9ubyBQ aGFybWFjZX V0aWNhbCBo YXMgYSBzdH JvbmcgZm9j dXMgb24gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 LCBpbnZlc3 RpbmcgYSBz aWduaWZpY2 FudCBwb3J0 aW9uIG9mIG l0cyByZXZl bnVlIGludG 8gdGhlIGRl dmVsb3BtZW 50IG9mIG5l dyBkcnVncy 4gVGhpcyBo YXMgYWxsb3 dlZCB0aGUg Y29tcGFueS B0byBpbnRy b2R1Y2UgaW 5ub3ZhdGl2 ZSBhbmQgZW ZmZWN0aXZl IHRyZWF0bW VudHMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMuPGJyPj IuIFN0cm9u ZyBQaXBlbG luZSBvZiBE cnVnczogT2 5vIFBoYXJt YWNldXRpY2 FsIGhhcyBh IHJvYnVzdC BwaXBlbGlu ZSBvZiBkcn Vncywgd2l0 aCBzZXZlcm FsIHBvdGVu dGlhbCBibG 9ja2J1c3Rl ciBkcnVncy BpbiBkZXZl bG9wbWVudC 4gVGhpcyBl bnN1cmVzIG EgY29udGlu dW91cyBzb3 VyY2Ugb2Yg cmV2ZW51ZS Bncm93dGgg aW4gdGhlIG Z1dHVyZS48 YnI+My4gR2 xvYmFsIFBy ZXNlbmNlOi BUaGUgY29t cGFueSBoYX MgYSBnbG9i YWwgcHJlc2 VuY2UsIHdp dGggb3Blcm F0aW9ucyBp biBKYXBhbi wgdGhlIFVu aXRlZCBTdG F0ZXMsIGFu ZCBFdXJvcG UuIFRoaXMg YWxsb3dzIG l0IHRvIHRh cCBpbnRvIG RpZmZlcmVu dCBtYXJrZX RzIGFuZCBy ZWFjaCBhIH dpZGVyIHBh dGllbnQgcG 9wdWxhdGlv bi48YnI+NC 4gU3RyYXRl Z2ljIFBhcn RuZXJzaGlw czogT25vIG hhcyBmb3Jt ZWQgc3RyYX RlZ2ljIHBh cnRuZXJzaG lwcyB3aXRo IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyBhbmQgYm lvdGVjaCBz dGFydHVwcy B0byBkZXZl bG9wIG5ldy BkcnVncyBh bmQgdGVjaG 5vbG9naWVz LiBUaGlzIG NvbGxhYm9y YXRpb24gaG VscHMgdGhl IGNvbXBhbn kgYWNjZXNz IGN1dHRpbm ctZWRnZSBy ZXNlYXJjaC BhbmQgZXhw YW5kIGl0cy Bwcm9kdWN0 IHBvcnRmb2 xpby48YnI+ NS4gQ29tbW l0bWVudCB0 byBJbm5vdm F0aW9uOiBP bm8gUGhhcm 1hY2V1dGlj YWwgaGFzIG Egc3Ryb25n IGNvbW1pdG 1lbnQgdG8g aW5ub3ZhdG lvbiBhbmQg aXMgY29uc3 RhbnRseSBp bnZlc3Rpbm cgaW4gbmV3 IHRlY2hub2 xvZ2llcyBh bmQgYXBwcm 9hY2hlcyB0 byBib29zdC BkcnVnIGRl dmVsb3BtZW 50IGFuZCBp bXByb3ZlIH BhdGllbnQg b3V0Y29tZX MuPGJyPjYu IEZvY3VzIG 9uIFJhcmUg RGlzZWFzZX M6IFRoZSBj b21wYW55IG hhcyBhIHN0 cm9uZyBmb2 N1cyBvbiBy YXJlIGRpc2 Vhc2VzLCB3 aGVyZSB0aG VyZSBpcyBh IHNpZ25pZm ljYW50IHVu bWV0IG1lZG ljYWwgbmVl ZC4gVGhpcy Bjb21taXRt ZW50IGhhcy BsZWQgdG8g dGhlIHN1Y2 Nlc3NmdWwg ZGV2ZWxvcG 1lbnQgb2Yg c2V2ZXJhbC BkcnVncyBm b3IgcmFyZS BkaXNlYXNl cy48YnI+Ny 4gU29jaWFs IFJlc3Bvbn NpYmlsaXR5 OiBPbm8gUG hhcm1hY2V1 dGljYWwgaG FzIGEgc3Ry b25nIGVtcG hhc2lzIG9u IHNvY2lhbC ByZXNwb25z aWJpbGl0eS BhbmQgaXMg Y29tbWl0dG VkIHRvIHBy b3ZpZGluZy BhZmZvcmRh YmxlIGFuZC BhY2Nlc3Np YmxlIG1lZG ljaW5lcyB0 byBwYXRpZW 50cyBpbiBu ZWVkLjxicj 44LiBTdHJv bmcgRmluYW 5jaWFsIFBl cmZvcm1hbm NlOiBUaGUg Y29tcGFueS BoYXMgY29u c2lzdGVudG x5IGFjaGll dmVkIHN0cm 9uZyBmaW5h bmNpYWwgcG VyZm9ybWFu Y2UsIHdpdG ggc3RlYWR5 IHJldmVudW UgYW5kIHBy b2ZpdCBncm 93dGguIFRo aXMgc3RhYm lsaXR5IGFu ZCBmaW5hbm NpYWwgc3Ry ZW5ndGggZ2 l2ZSB0aGVt IHRoZSByZX NvdXJjZXMg dG8gaW52ZX N0IGluIG5l dyBkcnVnIG RldmVsb3Bt ZW50Ljxicj 45LiBFbXBs b3llZS1Gcm llbmRseSBQ b2xpY2llcz ogT25vIGhh cyBiZWVuIH JlY29nbml6 ZWQgYXMgb2 5lIG9mIHRo ZSBiZXN0IG NvbXBhbmll cyB0byB3b3 JrIGZvciBp biBKYXBhbi 4gSXQgaGFz IGEgcG9zaX RpdmUgd29y ayBjdWx0dX JlIGFuZCBl bXBsb3llZS 1mcmllbmRs eSBwb2xpY2 llcywgd2hp Y2ggaGF2ZS BoZWxwZWQg YXR0cmFjdC BhbmQgcmV0 YWluIHRvcC B0YWxlbnQu PGJyPjEwLi BDb21taXRt ZW50IHRvIF N1c3RhaW5h YmlsaXR5Oi BPbm8gaXMg Y29tbWl0dG VkIHRvIHN1 c3RhaW5hYm xlIGRldmVs b3BtZW50IG FuZCBoYXMg c2V0IHRhcm dldHMgZm9y IHJlZHVjaW 5nIGl0cyBl bnZpcm9ubW VudGFsIGlt cGFjdC4gVG hlIGNvbXBh bnkgYWxzby BzdXBwb3J0 cyB2YXJpb3 VzIHNvY2lh bCBpbml0aW F0aXZlcyBh bmQgaXMgd2 9ya2luZyB0 b3dhcmRzIG J1aWxkaW5n IGEgbW9yZS BzdXN0YWlu YWJsZSBmdX R1cmUu
What the company's business model?
Ono Pharmaceutical

πŸ“ˆ Want to read more about Ono Pharmaceutical?

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

VGhlIE9uby BQaGFybWFj ZXV0aWNhbC BDb21wYW55 IGlzIGEgcG hhcm1hY2V1 dGljYWwgY2 9tcGFueSB0 aGF0IGZvY3 VzZXMgb24g dGhlIHJlc2 VhcmNoLCBk ZXZlbG9wbW VudCwgcHJv ZHVjdGlvbi wgYW5kIHNh bGUgb2YgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMu IFRoZWlyIG J1c2luZXNz IG1vZGVsIG lzIGJhc2Vk IG9uIHByb3 ZpZGluZyBp bm5vdmF0aX ZlIGFuZCBl ZmZlY3Rpdm UgbWVkaWNh bCBzb2x1dG lvbnMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMgYW5kIG 1lZGljYWwg Y29uZGl0aW 9ucy48YnI+ VGhleSBjb2 xsYWJvcmF0 ZSB3aXRoIH Jlc2VhcmNo IGluc3RpdH V0ZXMsIHVu aXZlcnNpdG llcywgYW5k IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyB0byBkZX ZlbG9wIG5l dyBkcnVncy BhbmQgdHJl YXRtZW50cy 4gT25vIFBo YXJtYWNldX RpY2FsIGFs c28gaGFzIG Egc3Ryb25n IGZvY3VzIG 9uIGludmVz dGluZyBpbi BjdXR0aW5n LWVkZ2UgdG VjaG5vbG9n aWVzIGFuZC Bjb250aW51 b3VzbHkgaW 1wcm92aW5n IHRoZWlyIG V4aXN0aW5n IHByb2R1Y3 RzLjxicj5U aGUgY29tcG FueSdzIG1h aW4gc291cm NlIG9mIHJl dmVudWUgY2 9tZXMgZnJv bSB0aGUgc2 FsZXMgb2Yg dGhlaXIgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMs IGJvdGggaW 4gSmFwYW4g YW5kIGludG VybmF0aW9u YWxseS4gVG hleSBoYXZl IGEgZGl2ZX JzZSBwb3J0 Zm9saW8gb2 YgcHJvZHVj dHMgdGhhdC Bjb3ZlciB2 YXJpb3VzIH RoZXJhcGV1 dGljIGFyZW FzLCBzdWNo IGFzIG9uY2 9sb2d5LCBp bW11bm9sb2 d5LCBuZXVy b2xvZ2ljYW wgZGlzb3Jk ZXJzLCBhbm QgaW5mZWN0 aW91cyBkaX NlYXNlcy48 YnI+T25vIF BoYXJtYWNl dXRpY2FsIG Fsc28gdXNl cyBhIGxpY2 Vuc2luZyBi dXNpbmVzcy Btb2RlbCB0 byBleHBhbm QgdGhlaXIg cHJvZHVjdC Bwb3J0Zm9s aW8gYnkgcG FydG5lcmlu ZyB3aXRoIG 90aGVyIGNv bXBhbmllcy B0byBkZXZl bG9wIGFuZC Bjb21tZXJj aWFsaXplIH RoZWlyIHBy b2R1Y3RzIG luIGRpZmZl cmVudCBtYX JrZXRzLiBU aGV5IGFsc2 8gb2ZmZXIg Y29udHJhY3 QgbWFudWZh Y3R1cmluZy BzZXJ2aWNl cyB0byBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMsIG dlbmVyYXRp bmcgYWRkaX Rpb25hbCBy ZXZlbnVlLj xicj5JbiBh ZGRpdGlvbi B0byB0aGVp ciBjb21tZX JjaWFsIGFj dGl2aXRpZX MsIE9ubyBQ aGFybWFjZX V0aWNhbCBh bHNvIGludm VzdHMgaW4g Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eSBpbml0aW F0aXZlcyB0 byBjb250cm lidXRlIHRv IHRoZSB3ZW xsLWJlaW5n IG9mIHNvY2 lldHkuIFRo aXMgaW5jbH VkZXMgc3Vw cG9ydGluZy BoZWFsdGhj YXJlLXJlbG F0ZWQgcHJv amVjdHMgYW 5kIGluaXRp YXRpdmVzIG luIGRldmVs b3BpbmcgY2 91bnRyaWVz Ljxicj5Pdm VyYWxsLCB0 aGUgY29tcG FueSdzIGJ1 c2luZXNzIG 1vZGVsIGZv Y3VzZXMgb2 4gY29udGlu dW91cyBpbm 5vdmF0aW9u LCBzdHJhdG VnaWMgY29s bGFib3JhdG lvbnMsIGFu ZCBldGhpY2 FsIGJ1c2lu ZXNzIHByYW N0aWNlcyB0 byBwcm92aW RlIGhpZ2gt cXVhbGl0eS BhbmQgZWZm ZWN0aXZlIG 1lZGljYWwg c29sdXRpb2 5zIGZvciBw YXRpZW50cy B3b3JsZHdp ZGUu
Interesting facts about the company
Ono Pharmaceutical

πŸ“ˆ Want to read more about Ono Pharmaceutical?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVE wySENGR0E3 dkdnVGtPa2 o0UGwud2Vi cCIgYWx0PS JPbm8gUGhh cm1hY2V1dG ljYWwiIHRp dGxlPSJPbm 8gUGhhcm1h Y2V1dGljYW wiICBjbGFz cz0iaW1nLW ZsdWlkIiBo ZWlnaHQ9OT Agd2lkdGg9 OTAgbG9hZG luZz0nbGF6 eScgc3R5bG U9J2JvcmRl ci1yYWRpdX M6IDZweDsn PgoKICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdmbG V4OiAxOyB0 ZXh0LWFsaW duOiBjZW50 ZXI7IG1hcm dpbi1sZWZ0 OiA1cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPHAgc3 R5bGU9J2Zv bnQtc2l6ZT ogMjZweDsg Y29sb3I6IC MzMzM7IG1h cmdpbi1ib3 R0b206IDE1 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIPCfk4 ggV2FudCB0 byByZWFkIG 1vcmUgYWJv dXQgT25vIF BoYXJtYWNl dXRpY2FsPw ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdpbmRl eC5waHA/cG FnZT1zaWdu dXAnIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICMw MDdCRkY7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogI2Zm ZjsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHBhZGRpbm c6IDEwcHgg MjBweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJvcm Rlci1yYWRp dXM6IDVweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH RleHQtZGVj b3JhdGlvbj ogbm9uZTsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGZv bnQtd2VpZ2 h0OiBib2xk OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luLX JpZ2h0OiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdHJhbn NpdGlvbjog YmFja2dyb3 VuZC1jb2xv ciAwLjNzIG Vhc2U7Jwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgb25t b3VzZW92ZX I9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA1NmIz IicKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IG9ubW91c2 VvdXQ9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA3 QkZGIic+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvYT4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxzcGFuIH N0eWxlPSdt YXJnaW46ID AgOHB4OyBj b2xvcjogIz U1NTsnPm9y PC9zcGFuPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naW5k ZXgucGhwP3 BhZ2U9bG9n aW4nIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGNvbG9y OiAjMDA3Qk ZGOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdGV4dC1k ZWNvcmF0aW 9uOiB1bmRl cmxpbmU7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBmb2 50LXdlaWdo dDogNTAwOy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bsb2cgaW4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgoK CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdtYX JnaW4tdG9w OiAxNXB4Oy Bmb250LXNp emU6IDEzcH g7IGZvbnQt d2VpZ2h0Oi Bib2xkOyBj b2xvcjogI2 QzMmYyZjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg 4pyN77iPIF NpZ24gdXAg dG8gZ2V0ID xpPiJUaGUg Q2hlY2tsaX N0IFZhbHVl IEludmVzdG 9yIOKAlCBB IFNtYXJ0ZX IgV2F5IHRv IFBpY2sgU3 RvY2tzIjwv aT4gZm9yIG ZyZWUKICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9wPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx MnB4OyBmb2 50LXNpemU6 IDEzcHg7IG NvbG9yOiAj NDQ0Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIG5v dyBhbmQgZ2 V0IG91ciBm cmVlIGVCb2 9rIAogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGI+VGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2Nrczwv Yj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIC0t PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8IS0t CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 1hcmdpbi10 b3A6IDE2cH g7IGZvbnQt c2l6ZTogMT RweDsgY29s b3I6ICM0ND Q7IGZvbnQt ZmFtaWx5Oi AtYXBwbGUt c3lzdGVtLC BCbGlua01h Y1N5c3RlbU ZvbnQsIFNl Z29lIFVJLC BSb2JvdG8s IEhlbHZldG ljYSBOZXVl LCBzYW5zLX NlcmlmOyBs aW5lLWhlaW dodDogMS42 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBIYXZlIH lvdSBoZWFy ZCBhYm91dC BvdXIgc2hv cnQgPHN0cm 9uZyBzdHls ZT0nZm9udC 13ZWlnaHQ6 IDYwMDsnPk RhaWx5IFZp ZGVvIE5ld3 NsZXR0ZXI8 L3N0cm9uZz 4/CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdodHRwcz ovL3d3dy5p bnNpZ2h0Zn VsdmFsdWUu Y29tL25ld3 NsZXR0ZXIu cGhwJyB0YX JnZXQ9J19i bGFuaycgc3 R5bGU9J2Nv bG9yOiAjMD A3QkZGOyB0 ZXh0LWRlY2 9yYXRpb246 IG5vbmU7IG ZvbnQtd2Vp Z2h0OiA1MD A7IG1hcmdp bi1sZWZ0Oi A2cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBGaW5kIG 91dCBtb3Jl CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 L2E+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAgICAgIC AgICAgICAt LT4KICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgCiAgICAg ICAgCiAgIC AgICAgPHNw YW4gY2xhc3 M9J2JsdXJy ZWQtdGV4dC c+CiAgICAg ICAgICAgIG JXRnJaWE1n ZEcgRmliR1 YwY3p4aSBj ajR4TGlCR2 IzIFZ1WkdW a0lHbHUgSU RFM01UYzZJ RiBSb1pTQl BibThnIFVH aGhjbTFoWT IgVjFkR2xq WVd3ZyBZMj l0Y0dGdWVT IEIzWVhNZ1 ptOTEgYm1S bFpDQnBiaS BBeE56RTNJ R0Z6IElHRW dkSEpoWkcg bDBhVzl1WV d3ZyBhR1Z5 WW1Gc0lHID FsWkdsamFX NWwgSUhOMG IzSmxJRyBs dUlFOXpZV3 RoIExDQktZ WEJoYmkgNG dTWFFnZDJG eiBJR05oYk d4bFpDIEJQ Ym04Z1IyVn UgZW1GbGJX OXVJRiBOb2 IzUmxiaTQ4 IFluSStNaT RnUlcgNTBa WEpsWkNCMC BhR1VnY0do aGNtIDFoWT JWMWRHbGog WVd3Z2FXNW tkWCBOMGNu a2dhVzRnIE 1UZzVPVG9n U1cgNGdNVG c1T1N3ZyBk R2hsSUdOdm JYIEJoYm5r Z2MzUmggY2 5SbFpDQnBi WCBCdmNuUn BibWNnIGNH aGhjbTFoWT IgVjFkR2xq WVd3ZyBjbU YzSUcxaGRH IFZ5YVdGc2 N5Qm0gY205 dElHRmljbS A5aFpDQmhi bVFnIFpXNT BaWEpsWkMg QjBhR1VnY0 doaCBjbTFo WTJWMWRHIG xqWVd3Z2FX NWsgZFhOMG Nua3VQRyBK eVBqTXVJRV pwIGNuTjBJ RXBoY0cgRn VaWE5sSUdO diBiWEJoYm 5rZ2RHIDhn YldGdWRXWm ggWTNSMWNt VWdjRyBWdW FXTnBiR3hw IGJqb2dTVz RnTVQgazBO aXdnVDI1di BJRkJvWVhK dFlXIE5sZF hScFkyRnMg SUdKbFkyRn RaUyBCMGFH VWdabWx5IG MzUWdTbUZ3 WVcgNWxjMl VnWTI5dCBj R0Z1ZVNCMG J5IEJ0WVc1 MVptRmogZE hWeVpTQnda VyA1cFkybH NiR2x1IExq eGljajQwTG kgQkVaWFps Ykc5dyBaV1 FnU21Gd1lX IDdpZ0psek lHWnAgY25O MElIUnlZVy A1eGRXbHNh WHBsIGNqb2 dTVzRnTVQg azFOU3dnZE dobCBJR052 YlhCaGJuIG tnWkdWMlpX eHYgY0dWa0 lFcGhjRyBG dTRvQ1pjeU JtIGFYSnpk Q0IwY20gRn VjWFZwYkds NiBaWElnWT JGc2JHIFZr SUVWc1pXNX AgZFcwZ1JX eHBlRyBseU xqeGljajQx IExpQk1ZWF Z1WTIgZ2di MllnWm1seS BjM1FnWkhK MVp5IEJtYj NJZ2FIbHcg WlhKMFpXNX phVyA5dU9p QkpiaUF4IE 9UWTNMQ0JQ Ym0gOGdVR2 hoY20xaCBZ MlYxZEdsal lXIHdnYkdG MWJtTm8gWl dRZ2RHaGxJ RyBacGNuTj BJR0Z1IGRH bG9lWEJsY2 4gUmxibk5w ZG1VZyBaSE oxWnlCcGJp IEJLWVhCaG JpQmogWVd4 c1pXUWdRMi BGd2IzUmxi aTQ4IFluSS tOaTRnU1cg NTBjbTlrZF dOMCBhVzl1 SUc5bUlIIF JvWlNCbWFY SnogZENCS1 lYQmhibSBW elpTMXRZV1 JsIElHRnVk R2xqWVcgNW paWElnWkhK MSBaem9nU1 c0Z01UIGsz TkN3Z2RHaG wgSUdOdmJY QmhibiBrZ2 FXNTBjbTlr IGRXTmxaQ0 IwYUcgVWda bWx5YzNRZy BTbUZ3WVc1 bGMyIFV0Yl dGa1pTQmgg Ym5ScFkyRn VZMiBWeUlH UnlkV2NnIF kyRnNiR1Zr SUUgSnZjMk 5vSUZCbyBZ WEp0WVN3Z2 QyIGhwWTJn Z2FYTWcgYz NScGJHd2dk MiBsa1pXeD VJSFZ6IFpX UWdkRzlrWV gga3VQR0p5 UGpjdSBJRU 52Ykd4aFlt IDl5WVhScG IyNGcgZDJs MGFDQk1hVy B4c2VUb2dT VzRnIE1Uaz RNaXdnVDIg NXZJRkJvWV hKdCBZV05s ZFhScFkyIE ZzSUdWdWRH VnkgWldRZ2 FXNTBieSBC aElHTnZiR3 hoIFltOXlZ WFJwYjIgNG dkMmwwYUNC RiBiR2tnVE dsc2JIIGtn WVc1a0lFTn YgYlhCaGJu a2dkRyA4Z1 pHVjJaV3h2 IGNDQmhibV FnYlcgRnlh MlYwSUhCby BZWEp0WVdO bGRYIFJwWT JGc0lIQnkg YjJSMVkzUn pJRyBsdUlF cGhjR0Z1IE xqeGljajQ0 TGkgQlFZWE owYm1WeSBj MmhwY0NCM2 FYIFJvSUVK eWFYTjAgYj J3dFRYbGxj biBNZ1UzRj FhV0ppIE9p QkpiaUF5TU QgQTJMQ0JQ Ym04ZyBVR2 hoY20xaFky IFYxZEdsal lXd2cgYzJs bmJtVmtJRy BGdUlHRm5j bVZsIGJXVn VkQ0IzYVgg Um9JRUp5YV hOMCBiMnd0 VFhsbGNuIE 1nVTNGMWFX SmkgSUdadm NpQjBhRyBV Z1kyOHRaR1 YyIFpXeHZj RzFsYm4gUW dZVzVrSUdO diBMV052Yl cxbGNtIE5w WVd4cGVtRj AgYVc5dUlH OW1JRyBSeW RXZHpJR1p2 IGNpQmpZVz VqWlggSXNJ R05sYm5SeS BZV3dnYm1W eWRtIDkxY3 lCemVYTjAg WlcwZ1pHbH piMyBKa1pY SnpMQ0JoIG JtUWdZWFYw YjIgbHRiWF Z1WlNCayBh WE5sWVhObG N5IDQ4WW5J K09TNGcgUj J4dlltRnNJ RyBWNGNHRn VjMmx2IGJq b2dUMjV2SU YgQm9ZWEp0 WVdObCBkWF JwWTJGc0lH IGhoY3lCbG VIQmggYm1S bFpDQnBkSC BNZ1luVnph VzVsIGMzTW dkRzhnYjMg WmxjaUE0Tk NCaiBiM1Z1 ZEhKcFpYIE 1nWVc1a0lI SmwgWjJsdm JuTWdZWCBK dmRXNWtJSF JvIFpTQjNi M0pzWkMgd2 dkMmwwYUNC aCBJR1p2WT NWeklHIDl1 SUVGemFXRX MgSUU1dmNu Um9JRSBGdF pYSnBZMkVz IElHRnVaQ0 JGZFggSnZj R1V1UEdKeS BQakV3TGlC VGRYIE4wWV dsdVlXSnMg WlNCa1pYWm xiRyA5d2JX VnVkRG9nIF ZHaGxJR052 YlggQmhibm tnYVhNZyBZ Mjl0YldsMG RHIFZrSUhS dklITjEgYz NSaGFXNWhZ bSB4bElHUm xkbVZzIGIz QnRaVzUwSU cgRnVaQ0Jv WVhNZyBjMl YwSUdkdllX IHh6SUhSdk lISmwgWkhW alpTQnBkSC BNZ1pXNTJh WEp2IGJtMW xiblJoYkMg QnBiWEJoWT NRcyBJSEJ5 YjIxdmRHIF VnWkdsMlpY SnogYVhSNU lHRnVaQyBC cGJtTnNkWE 5wIGIyNHNJ R0Z1WkMgQm piMjUwY21s aSBkWFJsSU hSdklIIE52 WTJsbGRIa2 cgZEdoeWIz Vm5hQyBCMl lYSnBiM1Z6 IElHbHVhWF JwWVggUnBk bVZ6TGc9PQ ogICAgICAg IDwvc3Bhbj 4KICAgICAg ICAKICAgIC AgICA=
See Company Q&A
Ono Pharmaceutical

πŸ“Š Get full analytics about Ono Pharmaceutical

Sign up for free or log in

πŸ’‘ Learn smarter stock picks with "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal